Clin Mol Hepatol.
2024 Oct;30(4):659-662. 10.3350/cmh.2024.0516.
Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
- Affiliations
-
- 1Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- KMID: 2560064
- DOI: http://doi.org/10.3350/cmh.2024.0516
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Concurrent transarterial radioembolization and combination atezolizumab/ bevacizumab treatment of infiltrative hepatocellular carcinoma with portal vein tumor thrombosis: a case report
- New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
- Hepatocellular Carcinoma with Segmental Portal Vein Invasion Exhibiting a Complete Response after Transarterial Radioembolization
- Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis
- Role of Yttrium-90 Radioembolization in the Management of Hepatocellular Carcinoma
